PTH and hyperphosphatemia: These events, as well as nephrocalcinosis, are known risks associated with conventional therapy.2, 24 In contrast, in the present study, we observed no changes in serum calcium or PTH concentrations, urine calcium excretion, nor renal nephrocalcinosis scores and no incidents of hyperphosphatemia.